Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Operating income

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Dec 31, 20253,123+941.00%
Dec 31, 2024300-120.49%
Dec 31, 2023-1,464-57.63%
Dec 31, 2022-3,455-47.37%
Dec 31, 2021-6,565+65.66%
Sep 30, 2021-3,963+119.23%
Sep 30, 2020-1,808-75.77%
Sep 30, 2019-7,460+440.74%
Sep 30, 2018-1,380-245.08%
Sep 30, 2017951+37.03%
Sep 30, 2016694+45.69%
Sep 30, 2015476+234.70%
Sep 30, 2014142

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat